Model architectures for bacterial membranes
- PMID: 35340604
- PMCID: PMC8921416
- DOI: 10.1007/s12551-021-00913-7
Model architectures for bacterial membranes
Abstract
The complex composition of bacterial membranes has a significant impact on the understanding of pathogen function and their development towards antibiotic resistance. In addition to the inherent complexity and biosafety risks of studying biological pathogen membranes, the continual rise of antibiotic resistance and its significant economical and clinical consequences has motivated the development of numerous in vitro model membrane systems with tuneable compositions, geometries, and sizes. Approaches discussed in this review include liposomes, solid-supported bilayers, and computational simulations which have been used to explore various processes including drug-membrane interactions, lipid-protein interactions, host-pathogen interactions, and structure-induced bacterial pathogenesis. The advantages, limitations, and applicable analytical tools of all architectures are summarised with a perspective for future research efforts in architectural improvement and elucidation of resistance development strategies and membrane-targeting antibiotic mechanisms.
Supplementary information: The online version contains supplementary material available at 10.1007/s12551-021-00913-7.
Keywords: Bacteria; Biophysics; Lipids; Membrane; Model membrane.
© The Author(s) 2022.
Conflict of interest statement
Conflict of interestThe authors declare no competing interests.
Figures
References
-
- Guidotti G (1972) The composition of biological membranes. Arch Intern Med 129(2):194–201. 10.1001/archinte.1972.00320020038003 - PubMed
-
- Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48(1):1–12. 10.1086/595011 - PubMed
-
- Del Mar CB, Scott AM, Glasziou PP, Hoffmann T, van Driel ML, Beller E, Phillips SM, Dartnell J (2017) Reducing antibiotic prescribing in Australian general practice: time for a national strategy. Med J Aust 207(9):401–406. 10.5694/mja17.00574 - PubMed
-
- Pendleton JN, Gorman SP, Gilmore BF (2013) Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 11(3):297–308. 10.1586/eri.13.12 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
